Hjem › Type 2-diabetes › Indiana
Type 2-diabetes kliniske forsøg i Indiana
18 studier for Type 2-diabetes søger deltagere på steder i Indiana.
Byer i Indiana
Officiel studietekst (engelsk)
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Franciscan Physician Network - Indiana Heart Physicians, Indianapolis
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07783802EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- American Health Network - Avon, Avon
- Midwest Cardiovascular Research and Education Foundation, Elkhart
- American Health Network - Greenfield, Greenfield
- og 2 flere
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07064473A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Indiana Medical Research Institute, Indianapolis
- Franciscan Physician Network- Indiana Heart Physicians, Indianapolis
RekruttererFrivillige med god helbredstilstand velkomne
Alder 55 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT06112418A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- MediSphere Medical Research Center, LLC, Evansville
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07595549A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- DM Clinical Research - Indianapolis, Indianapolis
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07282600A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Evansville
- AURORA-2 Clinical Site, Indianapolis
- AURORA-2 Clinical Site, Valparaiso
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 16. sep. 2026 · NCT07743450A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
- AES - DRS - Synexus Clinical Research US, Inc. - Evansville, Evansville
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 15. sep. 2026 · NCT07340320A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Investigators Research Group, Brownsburg
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 14. sep. 2026 · NCT06897475A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- Midwest Inst For Clin Res, Indianapolis
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 11. sep. 2026 · NCT07668388A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Evansville
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07662213A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- Riley Hospital For Children, Indianapolis
RekruttererFase 3
Alder 10 til 18 · Alle køn · Opdateret 9. sep. 2026 · NCT07282613AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- American Health Network of IN LLC_Franklin, Franklin
- American Health Network of Indiana, LLC_Greenfield, Greenfield
- American Health Network of IN LLC, Muncie
RekruttererFase 3
Alder 45 og opefter · Alle køn · Opdateret 1. sep. 2026 · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Evansville
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 31. aug. 2026 · NCT07662109Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
- The South Bend Clinic, South Bend
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 17. aug. 2026 · NCT07527650A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
- Center for Diabetes and Metabolic Diseases Indiana University, Indianapolis
RekruttererFase 3
Alder 10 til 17 · Alle køn · Opdateret 7. aug. 2026 · NCT06739122Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
- Indiana University, Indianapolis
Rekrutterer
Alder 14 til 75 · Alle køn · Opdateret 3. aug. 2026 · NCT07579702Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
- Indiana University, Bloomington
Rekrutterer
Alder 18 til 75 · Alle køn · Opdateret 3. aug. 2026 · NCT07521475Drug Interaction Potential of Pro-Inflammatory Conditions
- Indiana University Hospital, Indianapolis
RekruttererObservationsstudie
Alder 12 til 99 · Alle køn · Opdateret 22. jan. 2026 · NCT07360938Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.